Clinical Trial Update: Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Dispervise Ophthalmic Viscoelastic to ensure watertight wound closure after clear corneal cataract incisions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataracts

Drugs mentioned

• Dispervise Ophthalmic Viscoelastic

Snippet

Sponsor: Innovative Medical | Conditions: Cataracts | Phase 4 | Status: COMPLETED